InvestSMART

Pro Medicus Limited (ASX:PME)

ALERT: Price-sensitive ASX Announcement for PME
Current share price for PME : $198.980 29.51 (17.41%)+
Announcement
Release
12 Feb 2026 9:19AM
Price at Release
$169.470
Full Release
download
Summary
Pro Medicus Limited announced a significant increase in its financial performance for the six months ending December 2025. The company reported a 28.4% increase in revenue to $124.8 million and a 29.7% rise in underlying profit before tax to $90.7 million. The reported net profit after tax was $171.2 million, up 230.9%, which includes unrealised gains from an investment in 4D Medical Limited. Pro Medicus remains debt-free, with cash and financial assets rising to $221.8 million. A fully franked interim dividend of 32 cents per share was declared. The company secured seven new contracts worth over $280 million and plans to complete further implementations to drive future growth.
Key Points
  • Revenue increased by 28.4% to $124.8 million.
  • Underlying profit before tax rose by 29.7% to $90.7 million.
  • Reported net profit after tax surged by 230.9% to $171.2 million.
  • Unrealised gains from 4D Medical Limited investment included.
  • Cash and financial assets grew to $221.8 million.
  • The company remains debt-free.
  • Declared fully franked interim dividend of 32 cents per share.
  • Secured seven new contracts totaling over $280 million.
  • New contracts include offerings in cardiology and Visage 7 products.
  • Continued focus on cloud-based implementations and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.